Improving transplantation access, equity and outcomes through responsive risk communication and support for living donor candidates with obesity.
Project Number3R01DK137111-02S1
Former Number1R01DK137111-01
Contact PI/Project LeaderWATERMAN, AMY DOGGETTE
Awardee OrganizationMETHODIST HOSPITAL RESEARCH INSTITUTE
Description
Abstract Text
PROJECT SUMMARY
Kidney transplantation is an area of scarcity with demand for transplantable kidneys for those on the waiting list
continuing to outstrip supply. Increasing living donation rates, where someone donates one kidney while alive
to someone whose own kidneys don’t function, is the most promising way to increase the number of kidneys
available for transplant. Growing obesity rates, however, threaten to curb this supply, as having a high body
mass index (BMI) may rule out a potential living donor from evaluation. There is considerable disagreement
about the use of BMI as a determinant of eligibility with practices varying across and between countries and
transplant centers. Some say that risks can be modified or are justified. Reducing risks to potential living
donors would entail engagement with weight loss interventions. Access to and success of weight loss
interventions are highly variable.
Given these complexities and the need to increase the supply of organs, key ethical questions around risk,
fairness, and equity need to be examined and addressed for the involvement and protection of obese living
donors. It is vital to establish appropriate health screening measures and accurate and effective risk
communication for obese living donors. Understanding whether weight loss is desirable, accessible, or
achievable for those wishing to donate is important to providing responsive support. Discussions of what we
owe those taking the significant steps of both losing weight and donating an organ at personal risk to help
another are critically needed.
By first understanding current practice (Aim 1) and how excluded donors feel about risk and justice issues
related to weight loss and living donation (Aim 2), we will combine empirical findings, clinical evidence, and
normative analysis to generate expert recommendations for the decision-making and equitable support of
obese potential living donors (Aim 3).This project will build bioethics capacity by producing empirically informed
recommendations and drafting tools that support equitable practice in living donation, an area of scarcity with
great clinical and ethical complexity.
Public Health Relevance Statement
PROJECT NARRATIVE
Living kidney donation, where someone donates one kidney while alive to someone whose own kidneys don’t
function, provides the best outcomes for kidney patients needing renal replacement therapy. The growing
prevalence of obesity in society reduces the numbers of potential living donors, since motivated individuals
who have a high body mass index (BMI) are eliminated from being medically screened as donors and are not
offered any support to help them lose weight. There is an urgent need to address issues of fairness in
screening, comprehension of risks and benefits for both potential donors and recipients if a potential donor lost
weight, and, if indicated, access to weight loss education and support programs. By interviewing excluded
obese potential living donors about their views, experiences, and education and weight loss needs, this project
will produce empirically informed recommendations and draft tools that support ethical and equitable decisions
about living donation in situations when potential donors are obese.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcuteAddressAffectAltruismAreaBenefits and RisksBioethicsBody Weight decreasedBody mass indexCharacteristicsClinicalClinical ResearchCommunicationComprehensionComputerized Medical RecordCountryDataDecision AidDecision MakingDonor ExclusionsDonor SelectionEducationEffectivenessEligibility DeterminationEmotionalEnd stage renal failureEquityEthical AnalysisEthicsEvaluationExclusionHealthHypertensionIndividualInequityInterviewJusticeKidneyKidney TransplantationKnowledgeLiving DonorsMeasuresMedicalMethodsMotivationObesityOrganOutcomePatientsPopulationPrevalenceProcessProxyQuestionnairesRecommendationRenal Replacement TherapyResourcesRiskScholarshipSocietiesStructureSurveysTechniquesTestingTransplantationWaiting ListsWeightWorkaccess disparitiesclinical carediverse dataethnic minorityexperiencehealth assessmenthealth equityhigh body mass indeximprovedinformation gatheringinterestliving kidney donorobese personobesity riskpressureprogramsracial minorityscreeningsociodemographicssuccesssupport toolstransplant centersweight loss intervention
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
185641052
UEI
XJUCJAYJWYV1
Project Start Date
01-September-2023
Project End Date
31-May-2025
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$176,530
Direct Costs
$113,808
Indirect Costs
$62,722
Year
Funding IC
FY Total Cost by IC
2024
NIH Office of the Director
$176,530
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3R01DK137111-02S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01DK137111-02S1
Patents
No Patents information available for 3R01DK137111-02S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01DK137111-02S1
Clinical Studies
No Clinical Studies information available for 3R01DK137111-02S1
News and More
Related News Releases
No news release information available for 3R01DK137111-02S1
History
No Historical information available for 3R01DK137111-02S1
Similar Projects
No Similar Projects information available for 3R01DK137111-02S1